Merit Medical Systems (NASDAQ:MMSI) Stock Rating Lowered by Zacks Research

Merit Medical Systems (NASDAQ:MMSI) was downgraded by equities researchers at Zacks Research from a “strong-buy” rating to a “hold” rating in a research report issued on Monday, Zacks reports.

MMSI has been the topic of a number of other reports. Wells Fargo & Company upped their target price on Merit Medical Systems from $74.00 to $83.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. BTIG Research reissued a “buy” rating and set a $105.00 price target on shares of Merit Medical Systems in a research report on Tuesday, August 11th. JPMorgan Chase & Co. raised their price target on shares of Merit Medical Systems from $77.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Robert W. Baird set a $98.00 price target on shares of Merit Medical Systems in a research note on Friday, July 31st. Finally, Canaccord Genuity Group upped their price target on shares of Merit Medical Systems from $85.00 to $94.00 and gave the company a “buy” rating in a report on Friday, July 31st. Eight research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $100.00.

Merit Medical Systems Stock Up 1.4%

Shares of NASDAQ MMSI opened at $91.18 on Monday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.79 and a current ratio of 4.20. Merit Medical Systems has a 1 year low of $59.74 and a 1 year high of $94.75. The stock’s 50-day simple moving average is $88.30 and its 200-day simple moving average is $76.33. The firm has a market cap of $5.44 billion, a price-to-earnings ratio of 37.68, a PEG ratio of 2.25 and a beta of 0.51.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $0.96 by $0.23. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%. The firm had revenue of $418.84 million during the quarter, compared to the consensus estimate of $405.25 million. During the same quarter in the prior year, the business posted $1.01 earnings per share. Merit Medical Systems’s revenue for the quarter was up 9.5% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, equities analysts anticipate that Merit Medical Systems will post 3.84 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the company. Kilter Group LLC acquired a new position in shares of Merit Medical Systems in the 2nd quarter worth approximately $25,000. Harbor Investment Advisory LLC bought a new stake in shares of Merit Medical Systems in the 2nd quarter valued at approximately $50,000. IFP Advisors Inc increased its holdings in shares of Merit Medical Systems by 88.6% in the 3rd quarter. IFP Advisors Inc now owns 694 shares of the medical instruments supplier’s stock valued at $60,000 after acquiring an additional 326 shares during the last quarter. Farther Finance Advisors LLC raised its position in shares of Merit Medical Systems by 44.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 890 shares of the medical instruments supplier’s stock valued at $77,000 after acquiring an additional 272 shares in the last quarter. Finally, State of Wyoming acquired a new stake in shares of Merit Medical Systems during the 2nd quarter valued at approximately $79,000. Institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a medical device company that develops, manufactures and distributes disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in hospitals, outpatient facilities and other clinical settings.

The company’s product portfolio includes devices for vascular access, angiography, intervention, drainage, embolization, oncology and cardiac procedures. Merit also offers products used in peripheral intervention, spine procedures and other specialized areas of minimally invasive medicine, including kits, accessories and related procedural equipment.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through a global commercial and manufacturing network.